UMBF vs. ZYME

Last updated Apr 2, 2026

Compare and contrast key facts about UMB Financial Corporation (UMBF) and Zymeworks Inc. (ZYME).

Performance

UMBF vs. ZYME - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in UMB Financial Corporation (UMBF) and Zymeworks Inc. (ZYME). The values are adjusted to include any dividend payments, if applicable.

UMBF vs. ZYME - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UMBF UMB Financial Corporation	0.04%	3.44%	37.34%	2.21%	-19.97%	56.04%	2.64%	14.71%	-13.86%	0.34%
ZYME Zymeworks Inc.	-1.48%	79.85%	40.90%	32.19%	-52.04%	-65.32%	3.96%	209.67%	93.33%	-41.59%

Fundamentals

EPS UMBF : $13.90 ZYME : -$1.07
Total Revenue (TTM) UMBF : $4.25B ZYME : -$27.11M
Gross Profit (TTM) UMBF : $1.70B ZYME : -$27.11M
EBITDA (TTM) UMBF : $739.37M ZYME : -$79.57M

Returns By Period

In the year-to-date period, UMBF achieves a 0.04% return, which is significantly higher than ZYME's -1.48% return.

UMBF

• 1D: 1.65%
• 1M: -2.18%
• YTD: 0.04%
• 6M: -2.35%
• 1Y: 15.73%
• 3Y*: 27.91%
• 5Y*: 6.15%
• 10Y*: 10.10%

ZYME

• 1D: 3.59%
• 1M: 11.28%
• YTD: -1.48%
• 6M: 53.13%
• 1Y: 123.24%
• 3Y*: 42.10%
• 5Y*: -3.79%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

UMBF vs. ZYME — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UMBF

UMBF Risk / Return Rank: 56
UMBF Sharpe Ratio Rank: 58
UMBF Sortino Ratio Rank: 51
UMBF Omega Ratio Rank: 52
UMBF Calmar Ratio Rank: 59
UMBF Martin Ratio Rank: 59

ZYME

ZYME Risk / Return Rank: 92
ZYME Sharpe Ratio Rank: 92
ZYME Sortino Ratio Rank: 92
ZYME Omega Ratio Rank: 88
ZYME Calmar Ratio Rank: 94
ZYME Martin Ratio Rank: 92

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UMBF vs. ZYME - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for UMB Financial Corporation (UMBF) and Zymeworks Inc. (ZYME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UMBF	ZYME	Difference
Sharpe ratio Return per unit of total volatility	0.49	2.22	-1.73
Sortino ratio Return per unit of downside risk	0.86	3.14	-2.29
Omega ratio Gain probability vs. loss probability	1.12	1.38	-0.26
Calmar ratio Return relative to maximum drawdown	0.81	5.66	-4.85
Martin ratio Return relative to average drawdown	1.84	12.89	-11.04
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

UMBF vs. ZYME - Sharpe Ratio Comparison

The current UMBF Sharpe Ratio is 0.49, which is lower than the ZYME Sharpe Ratio of 2.22. The chart below compares the historical Sharpe Ratios of UMBF and ZYME, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	UMBF	ZYME	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.49	2.22	-1.73
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.19	-0.06	+0.25
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.30	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.25	0.13	+0.12

Correlation

The correlation between UMBF and ZYME is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

UMBF vs. ZYME - Dividend Comparison

UMBF's dividend yield for the trailing twelve months is around 1.45%, while ZYME has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
UMBF UMB Financial Corporation	1.45%	1.42%	1.39%	1.83%	1.78%	1.30%	1.81%	1.76%	1.92%	1.45%	1.28%	2.04%
ZYME Zymeworks Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

UMBF vs. ZYME - Drawdown Comparison

The maximum UMBF drawdown since its inception was -52.70%, smaller than the maximum ZYME drawdown of -91.81%. Use the drawdown chart below to compare losses from any high point for UMBF and ZYME.

Drawdown Indicators

	UMBF	ZYME	Difference
Max Drawdown Largest peak-to-trough decline	-52.70%	-91.81%	+39.11%
Max Drawdown (1Y) Largest decline over 1 year	-18.57%	-20.81%	+2.24%
Max Drawdown (5Y) Largest decline over 5 years	-50.25%	-87.84%	+37.59%
Max Drawdown (10Y) Largest decline over 10 years	-50.25%	—	—
Current Drawdown Current decline from peak	-14.32%	-54.34%	+40.02%
Average Drawdown Average peak-to-trough decline	-17.83%	-52.39%	+34.56%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.17%	9.14%	-0.97%

Volatility

UMBF vs. ZYME - Volatility Comparison

The current volatility for UMB Financial Corporation (UMBF) is 6.69%, while Zymeworks Inc. (ZYME) has a volatility of 14.12%. This indicates that UMBF experiences smaller price fluctuations and is considered to be less risky than ZYME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UMBF	ZYME	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.69%	14.12%	-7.43%
Volatility (6M) Calculated over the trailing 6-month period	21.08%	41.40%	-20.32%
Volatility (1Y) Calculated over the trailing 1-year period	32.18%	55.93%	-23.75%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	33.38%	62.51%	-29.13%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	33.53%	61.89%	-28.36%

Financials